The field of diabetes treatment is undergoing a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide are rapidly emerging as potential game-changers. These https://tomasczhf264639.ja-blog.com/39232988/novel-glp-1-receptor-agonists-retatrutide-and-trizepatide